FDx Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,897
| Closed | -$1.21M | – | 350 |
|
|
2024
Q1 | $1.21M | Sell |
2,897
-2,699
| -48% | -$1.13M | 0.18% | 119 |
|
|
2023
Q4 | $2.28M | Sell |
5,596
-133
| -2% | -$54.1K | 0.18% | 134 |
|
|
2023
Q3 | $1.99M | Sell |
5,729
-3,153
| -35% | -$1.1M | 0.17% | 130 |
|
|
2023
Q2 | $3.13M | Buy |
8,882
+1,695
| +24% | +$597K | 0.17% | 139 |
|
|
2023
Q1 | $2.08M | Hold |
7,187
| – | – | 0.09% | 191 |
|
|
2022
Q4 | $2.08M | Sell |
7,187
-1,107
| -13% | -$320K | 0.09% | 191 |
|
|
2022
Q3 | $2.4M | Sell |
8,294
-2,863
| -26% | -$829K | 0.11% | 167 |
|
|
2022
Q2 | $3.14M | Sell |
11,157
-2,335
| -17% | -$658K | 0.12% | 157 |
|
|
2022
Q1 | $3.52M | Sell |
13,492
-1,074
| -7% | -$280K | 0.12% | 146 |
|
|
2021
Q4 | $3.2M | Buy |
14,566
+4,443
| +44% | +$976K | 0.09% | 168 |
|
|
2021
Q3 | $1.84M | Buy |
10,123
+4,571
| +82% | +$829K | 0.06% | 221 |
|
|
2021
Q2 | $1.12M | Sell |
5,552
-148
| -3% | -$29.8K | 0.04% | 314 |
|
|
2021
Q1 | $1.23M | Buy |
5,700
+720
| +14% | +$155K | 0.05% | 251 |
|
|
2020
Q4 | $1.18M | Buy |
4,980
+807
| +19% | +$191K | 0.05% | 235 |
|
|
2020
Q3 | $1.14M | Sell |
4,173
-448
| -10% | -$122K | 0.05% | 219 |
|
|
2020
Q2 | $1.34M | Buy |
4,621
+1,168
| +34% | +$339K | 0.07% | 186 |
|
|
2020
Q1 | $822K | Sell |
3,453
-102
| -3% | -$24.3K | 0.05% | 218 |
|
|
2019
Q4 | $778K | Sell |
3,555
-436
| -11% | -$95.4K | 0.04% | 268 |
|
|
2019
Q3 | $676K | Buy |
3,991
+88
| +2% | +$14.9K | 0.05% | 289 |
|
|
2019
Q2 | $716K | Buy |
3,903
+225
| +6% | +$41.3K | 0.03% | 402 |
|
|
2019
Q1 | $677K | Sell |
3,678
-501
| -12% | -$92.2K | 0.03% | 389 |
|
|
2018
Q4 | $693K | Sell |
4,179
-320
| -7% | -$53.1K | 0.06% | 246 |
|
|
2018
Q3 | $867K | Sell |
4,499
-43
| -0.9% | -$8.29K | 0.03% | 368 |
|
|
2018
Q2 | $772K | Sell |
4,542
-726
| -14% | -$123K | 0.03% | 426 |
|
|
2018
Q1 | $859K | Sell |
5,268
-739
| -12% | -$121K | 0.03% | 556 |
|
|
2017
Q4 | $900K | Buy |
6,007
+798
| +15% | +$120K | 0.02% | 579 |
|
|
2017
Q3 | $792K | Buy |
5,209
+605
| +13% | +$92K | 0.02% | 607 |
|
|
2017
Q2 | $593K | Buy |
4,604
+1,277
| +38% | +$164K | 0.02% | 718 |
|
|
2017
Q1 | $364K | Buy |
3,327
+562
| +20% | +$61.5K | 0.01% | 905 |
|
|
2016
Q4 | $204K | Buy |
+2,765
| New | +$204K | 0.01% | 1082 |
|
|
2016
Q1 | – | Sell |
-3,429
| Closed | -$431K | – | 956 |
|
|
2015
Q4 | $431K | Buy |
+3,429
| New | +$431K | 0.02% | 612 |
|
|
2015
Q3 | – | Sell |
-2,168
| Closed | -$268K | – | 887 |
|
|
2015
Q2 | $268K | Sell |
2,168
-332
| -13% | -$41K | 0.01% | 791 |
|
|
2015
Q1 | $292K | Buy |
+2,500
| New | +$292K | 0.01% | 1235 |
|